A Phase 2 interventional study of Placebo and Brimonidine tartrate 0.025% in Ocular Redness, sponsored by Eye Therapies, LLC. Completed at 1 site in United States. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-07-31.
Sponsored by Eye Therapies, LLC · Phase 2, Interventional, and Treatment
The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects
133 studies on the registry are indexed under Erythema; 11 are open to participants now.
This study's enrollment of 57 is close to the median of 59 across 110 interventional studies indexed under Erythema.
Browse Erythema studies →Eye Therapies, LLC is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Placebo
Drug: Brimonidine tartrate 0.025%
1 drop in each eye daily for up to 35 days
1 drop in each eye for up to 35 days
Ocular redness
redness evaluated by investigator prior to study medication instillation and redness evaluated by the subject as captured in dosing diary
Time frame: at specified timepoints for up to 180 minutes
Ocular Redness
evaluated prior to study medication instillation and at 5 minutes post instillation
Time frame: up to 5 minutes post study medication instillation
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Eye Therapies, LLC